Skip to content
NBDC Human Database

No datasets in the cart.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research ID

hum0614-v1Release info

Latest

Research title

SIGNATURE : A translational omics and patient-tailored strategies for optimized management of childhood cancers in the province of Quebec over the continuum of care.

Research overview

Aims
The SIGNATURE program is a provincial precision medicine initiative in pediatric oncology that brings together Quebec's four university pediatric centers: CHU Sainte-Justine and the McGill University Health Centre (Montréal), the CHU de Sherbrooke (Estrie), and the CHU de Québec-Université Laval (Québec). SIGNATURE aims to perform large-scale genomic profiling of cancers in children and adolescents to identify known and novel molecular alterations with potential clinical relevance and help guide access to targeted therapies.
Methods
Following DNA extraction, DNA was sheared to ~12 kb fragments using Covaris G-tubes. Each sample was loaded onto a single FLO-PRO114M flow cell, sequenced on the PromethION 24 at the CRA-CHUSJ Meta-Platform for Integrated Genomics (MPGI). Library preparation was done following the manufacturer's protocol using the SQK-LSK114 kit from Oxford Nanopore Technologies (ONT).
Participants/materials
35 patients were enrolled in the SIGNATURE study, initiated in November 2019. Four control samples were derived from non tumoral tissue of participants with a cancer diagnosis (blood or bone marrow).
URL
N/A

Datasets

CartDataset IDType of dataPlatformsAccess criteriaDate published
JGAD001136NGS (Target Capture)
  • Oxford Nanopore Technologies PromethION
Controlled-access (Type I)

Data provider

Principal investigator
Vincent Philippe Lavallee
Affiliation
Hematology, Medicine, Pediatrics, CHU Sainte-Justine

Research projects

NameURL
SIGNATURE project
N/A

Grants

NameTitleProject number
Charles-Bruneau Foundation, CHU Sainte-Justine Foundation
SIGNATURE project
N/A
Azrieli Foundation
Precision Child Health Partnership (PCHP)
N/A

Related publications

TitleDOIDataset ID
Accelerated and Comprehensive Pediatric Cancer Profiling Using Whole-Genome Sequencing with Adaptive Sampling

Controlled access users

No use of the controlled access data has been recorded.